english.prescrire.org > Spotlight > 100 most recent > Melatonin (Adaflex°, Voquily°) in insomnia in children with ADHD

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Melatonin (Adaflex°, Voquily°) in insomnia in children with ADHD

 Marketing Authorisations  Patients with attention deficit hyperactivity disorder (ADHD) often have sleep disorders. Two melatonin-containing medicines have been authorised in France and elsewhere for use in insomnia in children and adolescents with ADHD in whom non-pharmacological measures have been insufficiently effective. Does melatonin improve sleep in this situation? Does it alleviate patients' behavioural and cognitive disorders, or improve the quality of life of the children concerned and their families? And what are its adverse effects?
Full article available for download by subscribers

 ©Prescrire 1 June 2025

Source: "Melatonin (Adaflex°, Voquily°) in insomnia in children with ADHD" Prescrire Int 2025; 34 (271): 145-147. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information

 
Share
Share on Facebook  
 
 
See also:

"Melatonin (Adaflex°,
Melatonin Noxarem°) in jet lag"
Prescrire Int 2025;
34 (271): 147-148.
Subscribers only

"Melatonin - Slenyto° for sleep
disorders in children with autism"
Prescrire Int 2020;
29 (218): 208-209.
Subscribers only

Melatonin: a review
of adverse effects reported
in France"
Prescrire Int 2019;
28 (202): 72-73.
Subscribers only